Submitted by Anonymous (not verified) on 7 June 2024 - 13:56
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 13, Status: Authorised